Nasdaq · Healthcare
electroCore, Inc. (ECOR)
As-reported financials and recent SEC filings for electroCore, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$32.0M
Net income
$-14.0M
Net margin
-43.6%
Diluted EPS
$-1.65
ROE
817.2%
P/E (TTM)
—
Market cap
—
Debt / equity
-3.9×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $32.0M | $25.2M | $16.0M | $8.6M | $5.5M |
| Gross profit | $27.8M | $21.4M | $13.2M | $7.0M | $4.1M |
| Operating income | $-13.2M | $-12.2M | $-19.3M | $-22.9M | $-20.0M |
| Net income | $-14.0M | $-11.9M | $-18.8M | $-22.2M | $-17.2M |
| Diluted EPS | $-1.65 | $-1.59 | $-2520.54 | $-2.96 | $-2.76 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-12
View on EDGAR →42026-05-29
View on EDGAR →1442026-05-27
View on EDGAR →1442026-05-27
View on EDGAR →42026-05-26
View on EDGAR →42026-05-22
View on EDGAR →1442026-05-14
View on EDGAR →10-Q2026-05-06
View on EDGAR →Largest Healthcare peers
Go deeper on ECOR
Search electroCore, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.